As of May 21, 2025, NanoString Technologies Inc (NSTG) reports a Gross Margin of 48.55%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of NanoString Technologies Inc's Gross Margin
Over recent years, NanoString Technologies Inc's Gross Margin has shown a moderate pattern. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2022-12-31 | 48.55% |
| 2021-12-31 | 52.93% |
| 2020-12-31 | 55.33% |
| 2019-12-31 | 64.97% |
| 2018-12-31 | 65.98% |
This slight downward trend highlights how NanoString Technologies Inc manages its operational efficiency and pricing power over time.
Comparing NanoString Technologies Inc's Gross Margin to Peers
To better understand NanoString Technologies Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| NanoString Technologies Inc (NSTG) | 48.55% |
| Sona Nanotech Inc (SONA.CN) | 7775.20% |
| Immunoprecise Antibodies Ltd (IPA.V) | 6441.49% |
| PerkinElmer Inc (PKI) | 6008.00% |
| Berkeley Lights Inc (BLI) | 68.43% |
| 10X Genomics Inc (TXG) | 67.91% |
Compared to its competitors, NanoString Technologies Inc's Gross Margin is among the lowest compared to peers, suggesting potential challenges in production costs or pricing strategy.